SUBCLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Clinical trials for SUBCLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE explained in plain language.
Never miss a new study
Get alerted when new SUBCLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE trials appear
Sign up with your email to follow new studies for SUBCLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Aspirin for silent heart disease: is a big study feasible?
Disease control Not yet recruitingThis pilot study checks whether a large-scale trial comparing low-dose aspirin to no aspirin is practical for people with early, symptom-free coronary artery disease. It will enroll 48 adults with signs of artery narrowing but no symptoms. The main goal is to see how many patient…
Matched conditions: SUBCLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Phase: PHASE3 • Sponsor: Montreal Heart Institute • Aim: Disease control
Last updated Jun 07, 2026 11:33 UTC
-
Silent artery changes linked to brain fog? landmark study to find out
Knowledge-focused Not yet recruitingThis study looks at 1,000 adults to see if early, symptom-free hardening of the arteries is connected to changes in memory and thinking. Participants will get non-invasive scans and thinking tests. The goal is to better understand how blood vessel health affects the brain and hea…
Matched conditions: SUBCLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 07, 2026 11:30 UTC